Skip to main content

Table 1 Characteristics of survey respondents

From: Experiences of and recommendations on clinical trial design in Alzheimer’s disease from the participant’s point of view: a mixed-methods study in two clinical trial centers in the Netherlands

Characteristics

All survey respondents

Alzheimer dementia

Mild cognitive impairment

Cognitively normal

p-value

N

71

33

19

19

 

Age, mean (±SD)

68.7 (6.5)

Range = 51–82

67.6 (7.9)

Range = 51–81

68.8 (8.8)

Range = 53–82

69.9 (4.1) b

Range = 63–82

.56

Female, n (%)

38 (54)

21 (64)

10 (53)

7 (37)

.17

Education level, n (%)

    

.18

 Up to secondary school completed

23 (32)

13 (39)

6 (32)

4 (21)

 

 Vocational training, diploma

11 (16)

5 (15)

5 (26)

1 (5)

 

 University degree

37 (52)

15 (46)

8 (42)

14 (74)

 

Participated in a number of clinical trials

 1/2/3, n

45/17/ 9

19/9/5

9/6/4

17/2/0

.02^

Completed participation in clinical triala

32 (45%)

18 (55%)

7 (37%)

7 (37%)

.15

Study partner

19 (7%)

16 (49%)

3 (16%)

0 (0%)

<.01

  1. Data are represented as mean (SD) or as n (%)
  2. aData were available for n=66
  3. bData available for n=18
  4. ^Tested for 1 versus multiple trial participations